Apollon Wealth Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
70,019
+9,822
+16% +$141K 0.01% 708
2026
Q1
$864K Buy
60,197
+13,102
+28% +$195K 0.01% 658
2025
Q4
$709K Buy
47,095
+13,012
+38% +$195K 0.01% 705
2025
Q3
$491K Buy
34,083
+10,194
+43% +$145K 0.01% 834
2025
Q2
$341K Buy
+23,889
New +$341K 0.01% 964

Other funds holding BMEZ

Apollon Wealth Management's BMEZ Position: Q2 2026 in Review

Apollon Wealth Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 16% in Q2 2026, buying an estimated $141K and bringing the position to 70,019 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #708.

Apollon Wealth Management first reported a position in BMEZ in Q2 2025 and has held it in 5 quarters since. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Apollon Wealth Management held 70,019 shares of BlackRock Health Sciences Trust II worth $1.07M as of Q2 2026.
  • Apollon Wealth Management bought 9,822 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $141K.
  • BlackRock Health Sciences Trust II made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #708 holding.
  • Apollon Wealth Management first reported a position in BlackRock Health Sciences Trust II in Q2 2025 and has held it in 5 quarters since.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.